{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:19:04Z","timestamp":1788211144248,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970413"],"award-info":[{"award-number":["81970413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270521"],"award-info":[{"award-number":["82270521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.avsg.2026.06.009","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:18:10Z","timestamp":1782314290000},"page":"151-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of Chronic Kidney Disease Severity and Drug-Coated Devices on 2-Year Clinically Driven Target Lesion Revascularization After Femoropopliteal Endovascular Intervention"],"prefix":"10.1016","volume":"132","author":[{"given":"Jun","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2026.06.009_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jvs.2010.03.050","article-title":"Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent","volume":"52","author":"Soga","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.06.009_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","article-title":"Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT global study","volume":"11","author":"Micari","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2026.06.009_bib3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jvs.2019.02.030","article-title":"Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts","volume":"70","author":"Shishehbor","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.06.009_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2026.06.009_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the eluvia polymer-coated drug-eluting stent and the zilver PTX polymer-free drug-coated stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2026.06.009_bib6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.06.009_bib20","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.06.009_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2026.06.009_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jvs.2008.04.059","article-title":"Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions","volume":"48","author":"Baril","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.06.009_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","article-title":"Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care","volume":"60","author":"Garimella","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.avsg.2026.06.009_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.avsg.2026.06.009_bib10","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.1999.00668.x","article-title":"Nontraumatic lower extremity amputations in the medicare end-stage renal disease population","volume":"56","author":"Eggers","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.avsg.2026.06.009_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jvs.2013.09.006","article-title":"Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention","volume":"59","author":"Patel","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.06.009_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1681\/ASN.2004050409","article-title":"Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease","volume":"16","author":"O'Hare","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.avsg.2026.06.009_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1358863X221148521","article-title":"Use of drug-coated balloons and stents in patients with femoropopliteal artery disease and severe chronic kidney disease","volume":"28","author":"Castro-Dominguez","year":"2023","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2026.06.009_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.06.009_bib16","article-title":"Uremic serum damages endothelium by provoking excessive neutrophil extracellular trap formation","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.avsg.2026.06.009_bib8","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.avsg.2026.06.009_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12882-019-1506-8","article-title":"Uric acid regulates NLRP3\/IL- 1\u03b2 signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K+efflux","volume":"20","author":"Yin","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.avsg.2026.06.009_bib14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jvir.2016.04.036","article-title":"Impact of chronic kidney disease on clinical outcomes of endovascular treatment for femoropopliteal arterial disease","volume":"27","author":"Heideman","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2026.06.009_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","article-title":"Targeting innate immunity-driven inflammation in CKD and cardiovascular disease","volume":"18","author":"Speer","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.avsg.2026.06.009_bib18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gfv418","article-title":"Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease","volume":"31","author":"Chen","year":"2016","journal-title":"Nephrol Dial Transpl"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626004450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626004450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:35:52Z","timestamp":1788208552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509626004450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":22,"alternative-id":["S0890509626004450"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2026.06.009","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Chronic Kidney Disease Severity and Drug-Coated Devices on 2-Year Clinically Driven Target Lesion Revascularization After Femoropopliteal Endovascular Intervention","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2026.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}